Liquid Biopsy for Precision Oncology Summit West Coast leaderboard
  • Friday, November 20, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

SmartLab Exchange Europe 2027 Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Page 14

Roche Opens Boston Innovation Center to Expand US Drug Research

Sep 18, 2026
Roche and Genentech have opened a new innovation center in Boston, Massachusetts, expanding their research and development presence in one of the world's major life sciences hubs.…
Read More...

Novo Nordisk Gets Positive EU Opinion for Sogroya in Short Stature

Sep 18, 2026
Novo Nordisk has received a positive recommendation from the Committee for Medicinal Products for Human Use (CHMP) for the use of Sogroya in children with idiopathic short stature (ISS)…
Read More...

Roche’s Lunsumio Combo Improves Progression-Free Survival in Follicular Lymphoma

Sep 17, 2026
Roche has reported positive Phase 3 results for Lunsumio (mosunetuzumab) combined with lenalidomide in people with relapsed or refractory follicular lymphoma. The CELESTIMO study met…
Read More...

Novo Nordisk Gets Positive EU Opinion for FREHEMGO in Haemophilia A

Sep 17, 2026
Novo Nordisk has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) recommending marketing authorisation for FREHEMGO (denecimig) to treat…
Read More...

WuXi XDC Licenses ADC Technology to Ona Therapeutics

Sep 17, 2026
WuXi XDC has entered into an out-licensing agreement with Ona Therapeutics to support the development of a new antibody-drug conjugate (ADC) for treatment-resistant cancers. Under…
Read More...

Sling Therapeutics Raises $123 Million for Thyroid Eye Disease Drug

Sep 17, 2026
Sling Therapeutics has raised $123 million in a Series C financing to advance linsitinib, an oral drug being developed for thyroid eye disease (TED). The financing was led by…
Read More...

Viatris Wins Japan Approval for WAKIX in Sleep Disorders

Sep 17, 2026
Viatris has received approval from Japan’s Ministry of Health, Labour and Welfare for WAKIX (pitolisant) to treat excessive daytime sleepiness (EDS) linked to obstructive sleep apnea…
Read More...

Cellares Partners With GenomeFrontier on Automated CAR-T Manufacturing

Sep 17, 2026
Cellares has partnered with Taiwanese cell therapy company GenomeFrontier Therapeutics to evaluate automated manufacturing for GF-CART01, an investigational CAR-T cell therapy being…
Read More...

Novo Nordisk Partners With Anthropic to Advance AI Drug Discovery

Sep 16, 2026
Novo Nordisk has partnered with artificial intelligence company Anthropic to use AI to speed up drug discovery, support research and improve software development across its…
Read More...

QurCan and Lilly Partner on CNS and PNS Genetic Medicines

Sep 16, 2026
QurCan Therapeutics has entered into an exclusive research and collaboration agreement with Eli Lilly and Company to develop genetic medicine treatments for diseases affecting the…
Read More...
Previous 1 … 12 13 14 15 16 … 966 Next
Oligonucleotide-based Therapeutics Summit
LEAP HR: Life Sciences Europe
3rd Annual TRP Target Selection & Drug Design Summit
2nd Structure-Based Drug Design Summit San Diego
Liquid Biopsy for Precision Oncology Summit West Coast
2nd Non-Opioid Pain Therapeutics Summit
Muscular Disorders Drug Development Summit
Amylin-Based Therapeutics Summit
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Antigen-Specific Immune Tolerance Summit
7th Operationalize Expanded Access Programs Summit
Viral Vector Process Development & Manufacturing Summit
SmartLab Exchange Europe 2027
8th RNAi-Based Therapeutics Summit
17th World ADC London
PFS & Injectable Drug Devices Europe
Ophthalmic Drug Delivery Summit
Obesity & Weight Loss Drug Development Summit West
ADC Payload Summit 2026
10th Antifibrotic Drug Development Summit 2026
Biomarker Operations & Biospecimen Management
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • OBI Pharma Signs $2 Billion ADC Deal with Novartis
  • Erasca and Bristol Myers Squibb Partner on Pancreatic Cancer Treatment
  • GSK Wins FDA Approval for Nelkarmi in Advanced Lung Cancer
  • OXB Partners with Aura Biosciences for Phase 3 Cancer Drug Development
  • Skylark Bio Advances Hearing Loss Gene Therapy to Younger Children

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Cell Therapy Safety in Autoimmune Disease

7th Operationalize: Expanded Access Programs Summit East…

As AI and ICH M15 Transform Drug Development, Industry…

Industry Leaders Explore the Future of RNA Therapeutics…

Direct RNA Binding Emerges as a Powerful Approach for…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.